Health Condition 1: L811- Chloasma
Conditions
Interventions
Intervention1: Topical Unani Formulation (Tila): Topical Unani Formulation (Tila)
Dosage Form : Tila (liniment)
Dose : The participants will be advised to apply the
prepared Tila on the affected site
Sponsors
Government Nizamia Tibbi College
Eligibility
Inclusion criteria
Inclusion criteria: Participants having single or multiple, symmetrical or asymmetrical brown macules on face (cheeks, nose, forehead, upper lip and chin) Chronicity more than 4 months
Exclusion criteria
Exclusion criteria: Pregnant and lactating women,Known cases of significant Pulmonary ,Cardiovascular,Hepato-renal Dysfunction,Malignancy, Endocrine disorders, HIV infection, AIDS, etc.,Known allergy,sensitivity or intolerance to the study drug or any of its ingredients,Participants with active alcohol intake and/or drug abuse,Those unwillingly to come for regular followup for the entire duration of the study and any patient considered not eligible in the investigator s discretion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Mean MASI Score from baseline to 2nd, 4th, and 6th week post treatmentTimepoint: Change in Mean MASI Score from baseline to 2nd, 4th, and 6th week post treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in Melasma Quality of Life assessment will be done at baseline & 6th week post treatmentTimepoint: Changes in Melasma Quality of Life assessment will be done at baseline & 6th week post treatment | — |
Countries
India
Contacts
Public ContactDr Muzammil Mushtaq Hussain
Government Nizamia Tibbi College
Outcome results
None listed